top of page

Funding

Canadian Institution of Health Research (CIHR)

2026-2031   Measuring the impact of transient microvascular blockage on dynamic oxygen delivery and brain damage (Co-Principal Investigator)

2023-2030  Sexual dimorphism and menopause in the interaction between immune cells and neurovascular coupling (Principal Investigator).


2021-2027    Immune cells and neurovascular coupling in Alzheimer's disease (Principal Investigator).
 

Alzheimer's Association, strategic fund: vascular contributions to cognitive impairment and dementia

2026-2029  Endothelial health benefits with cholesteryl ester transfer protein inhibition (Co-Principal Investigator)

Canadian Consortium on Neurodegeneration in Aging (CCNA)- Vascular team

2025-2029  Investigating cellular biomarkers of vascular white matter injury in neurodegeneration (Co-Applicant)

The Fonds de Recherche du Québec-Santé (FRQS)

2024-2027  Impact of vascular dysfunctions on neurological functions and brain aging (Principal Investigator)

Memberships

logo CRSNG.png
sqha.png
IRSC.png
grsnc.png
FRQS_RGB(multimedia-transparent).png
IUGM_recherche_rgb_edited.png
maladie du coeur.png
RBIQ_standard.gif
ERA-CVD-removebg.png
Circa Horizontal Full Transparent.png
Covid-logo.png
CCNA_logo.png
CFFI.gif
RQRV.png

Contact

Université de Montréal

Département de Pharmacologie et Physiologie

Pavillon Paul G Desmarais, bureau 3159

2960 Ch de la tour

Montréal (Québec) H3T 1N8

Canada

​

(514) 343-6111 # 32786

​

​

Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal

4545 chemin Queen-Mary, Bureau M4829
Montréal, Québec, H3W 1W5
Canada

(514) 340-3540 #4020

​

helene.girouard@umontreal.ca

​

2026, all rights reserved

Design: D. Vallerand

bottom of page